藤野 直也

Medicine & Life Sciences

1. Chronic Obstructive Pulmonary Disease 100%
2. Lung 70%
3. Alveolar Epithelial Cells 60%
4. Stem Cells 30%
5. Growth Differentiation Factors 30%
6. Factor XI 30%
7. Epithelial Cells 27%
8. Muscarinic Antagonists 25%
9. Systematic Reviews 20%
10. Interleukin-33 18%
11. Pyroglyphidae 17%
12. axl receptor tyrosine kinase 17%
13. Emphysema 16%
14. Acute Lung Injury 16%
15. Pulmonary Fibrosis 15%
16. Meta-Analysis 15%
17. Idiopathic Pulmonary Fibrosis 14%
18. Epithelial-Mesenchymal Transition 14%
19. persulfides 14%
20. Surface-Active Agents 14%
21. Obstructive Lung Diseases 13%
22. human IL33 protein 13%
23. Lung Injury 13%
24. cadherin 5 13%
25. Lung Diseases 13%
26. Transcriptome 12%
27. Organ Preservation Solutions 12%
28. E-Selectin 11%
29. Oxidative Stress 11%
30. Publications 11%
31. Messenger RNA 11%
32. Endothelial Cells 11%
33. polysulfide 11%
34. Secretory Proteinase Inhibitory Proteins 11%
35. Phosphotransferases 10%
36. Protein C 10%
37. Lymphangioleiomyomatosis 10%
38. Gene Expression 9%
39. Bronchiolo-Alveolar Adenocarcinoma 9%
40. Bleomycin 9%
41. Macrophages 9%
42. Alveolar Macrophages 9%
43. Nitrosative Stress 9%
44. Multipotent Stem Cells 9%
45. trichostatin A 9%
46. Phosphatidylserines 9%
47. Regeneration 9%
48. Receptor for Advanced Glycation End Products 9%